GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » Debt-to-Revenue

Etropal AD (XBUL:ETR) Debt-to-Revenue : N/A (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Etropal AD Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Etropal AD's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was лв3.60 Mil. Etropal AD's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was лв1.21 Mil. Etropal AD's annualized Revenue for the quarter that ended in Dec. 2023 was лв0.00 Mil.


Etropal AD Debt-to-Revenue Historical Data

The historical data trend for Etropal AD's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etropal AD Debt-to-Revenue Chart

Etropal AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.71 0.37 0.82 0.43

Etropal AD Quarterly Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 1.11 1.60 0.67 N/A

Competitive Comparison of Etropal AD's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Etropal AD's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Etropal AD's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Etropal AD's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Etropal AD's Debt-to-Revenue falls into.


;
;

Etropal AD Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Etropal AD's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.603 + 1.212) / 11.199
=0.43

Etropal AD's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.603 + 1.212) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Etropal AD Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Etropal AD's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Etropal AD Business Description

Traded in Other Exchanges
N/A
Address
191 Rusky Boulevard, Etropole, Sofia, BGR, 2180
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.